Business Description
ACI Formulations Ltd
ISIN : BD0480ACIFL4
Description
ACI Formulations Ltd is an agricultural chemicals manufacturer. The principal activities of the company are manufacturing and marketing a number of agrochemical and consumer products. The company has structured its operations into the following business segments - Crop Care and Public Health segment, which manufactures and sell crop care and public health products; Mosquito Coil segment is engaged in the manufacturing and selling of mosquito coil products; the Aerosol segment is engaged in the manufacturing and selling aerosol and air freshener products; and Paint segment which manufactures and sells paint products. It derives key revenue from the Crop Care and Public Health segment.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | 0.44 | |||||
| Debt-to-Equity | 0.97 | |||||
| Debt-to-EBITDA | 4.62 | |||||
| Interest Coverage | 2.15 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.2 | |||||
| Beneish M-Score | -2.62 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.1 | |||||
| 3-Year EBITDA Growth Rate | 14.1 | |||||
| 3-Year EPS without NRI Growth Rate | 36.3 | |||||
| 3-Year Book Growth Rate | 8.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 67.31 | |||||
| 9-Day RSI | 59.57 | |||||
| 14-Day RSI | 55.65 | |||||
| 6-1 Month Momentum % | -7.62 | |||||
| 12-1 Month Momentum % | -28.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.24 | |||||
| Quick Ratio | 0.94 | |||||
| Cash Ratio | 0.03 | |||||
| Days Inventory | 144.35 | |||||
| Days Sales Outstanding | 105.31 | |||||
| Days Payable | 12.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.59 | |||||
| Dividend Payout Ratio | 0.42 | |||||
| 3-Year Dividend Growth Rate | -9.1 | |||||
| Forward Dividend Yield % | 1.59 | |||||
| 5-Year Yield-on-Cost % | 2.09 | |||||
| Shareholder Yield % | 8.26 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 27.72 | |||||
| Operating Margin % | 11.38 | |||||
| Net Margin % | 5.69 | |||||
| FCF Margin % | 16.22 | |||||
| ROE % | 8.96 | |||||
| ROA % | 4.03 | |||||
| ROIC % | 6.96 | |||||
| ROC (Joel Greenblatt) % | 12.34 | |||||
| ROCE % | 18.61 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 21.63 | |||||
| PE Ratio without NRI | 21.63 | |||||
| Shiller PE Ratio | 23.08 | |||||
| Price-to-Owner-Earnings | 6.8 | |||||
| PEG Ratio | 3.38 | |||||
| PS Ratio | 1.23 | |||||
| PB Ratio | 1.89 | |||||
| Price-to-Tangible-Book | 1.84 | |||||
| Price-to-Free-Cash-Flow | 7.6 | |||||
| Price-to-Operating-Cash-Flow | 6.43 | |||||
| EV-to-EBIT | 14.11 | |||||
| EV-to-EBITDA | 13.18 | |||||
| EV-to-Revenue | 1.8 | |||||
| EV-to-FCF | 10.81 | |||||
| Price-to-Projected-FCF | 1.22 | |||||
| Price-to-DCF (Earnings Based) | 1.82 | |||||
| Price-to-DCF (FCF Based) | 0.64 | |||||
| Price-to-Median-PS-Value | 0.68 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.13 | |||||
| Price-to-Graham-Number | 1.31 | |||||
| Price-to-Net-Current-Asset-Value | 9.38 | |||||
| Earnings Yield (Greenblatt) % | 7.07 | |||||
| FCF Yield % | 13.58 | |||||
| Forward Rate of Return (Yacktman) % | 15.57 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ACI Formulations Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil BDT) | 4,974.823 | ||
| EPS (TTM) (BDT) | 5.988 | ||
| Beta | 0 | ||
| Volatility % | 33.11 | ||
| 14-Day RSI | 55.65 | ||
| 14-Day ATR (BDT) | 5.425476 | ||
| 20-Day SMA (BDT) | 121.535 | ||
| 12-1 Month Momentum % | -28.06 | ||
| 52-Week Range (BDT) | 107.5 - 159.8 | ||
| Shares Outstanding (Mil) | 47.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ACI Formulations Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ACI Formulations Ltd Stock Events
| Event | Date | Price(BDT) | ||
|---|---|---|---|---|
| No Event Data | ||||
ACI Formulations Ltd Frequently Asked Questions
What is ACI Formulations Ltd(DHA:ACIFORMULA)'s stock price today?
The current price of DHA:ACIFORMULA is BDT125.70. The 52 week high of DHA:ACIFORMULA is BDT159.80 and 52 week low is BDT107.50.
When is next earnings date of ACI Formulations Ltd(DHA:ACIFORMULA)?
The next earnings date of ACI Formulations Ltd(DHA:ACIFORMULA) is .
Does ACI Formulations Ltd(DHA:ACIFORMULA) pay dividends? If so, how much?
The Dividend Yield %  of ACI Formulations Ltd(DHA:ACIFORMULA) is 1.59% (As of Today), Highest Dividend Payout Ratio of ACI Formulations Ltd(DHA:ACIFORMULA) was 1.7. The lowest was 0.34. And the median was 0.58. The  Forward Dividend Yield % of ACI Formulations Ltd(DHA:ACIFORMULA) is 1.59%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers